Vaccines and antigens and toxoids

Anti-DUX4 Antibody is suitable for use in WB, IF, and IHC. Specific conditions for reactivity should be optimized by the end user.

Anti-TOX Antibody has been tested for use in ELISA, Western Blotting and Immunofluorescence. Specific conditions for reactivity should be optimized by the end user.

IL-17A is suitable as a control for polyclonal or monoclonal anti-IL-17A in immunological assays.

IL-17F is suitable as a control for polyclonal or monoclonal anti-IL-17F in immunological assays.

IL-17A is suitable as a control for polyclonal or monoclonal anti-IL-17A in immunological assays.

IL-3 is suitable as a control for polyclonal or monoclonal anti-IL-3 in immunological assays. Buffer formation: 10 mM sodium phosphate, 50 mM sodium chloride, pH 7.5.

IL-17F is suitable as a control for polyclonal or monoclonal anti-IL-17F in immunological assays.

IL-17A monoclonal antibody has been tested for use in western blotting, flow cytometry and ELISA. Specific conditions for reactivity should be optimized by the end user.

The RPI human tissue interleukin 2 is suitable for use in research facilities and chemical laboratories to conduct wide range of experiments. It is available in sturdy bottle that endures heavy and rigorous usage.

Antigen: synthetic peptide from human cRBP7 amino acids 125-134 (QVCKQTFQRA) Host: rabbit Cross Reactivity: (+) human, mouse, rat, and African green monkey cRBP7 other species not tested Applications: WB and IHC

Antigen: human EP1 receptor C-terminal amino acids 380-402 Host: rabbit Application(s): ICC and WB Binding of PGE2 to the EP1 receptor results in an increase in phosphatidyl inositol turnover with subsequent increase in intracellular free Ca2+.

Antigen: purified enzyme from mouse macrophages (RAW 264.7 cells) Host: rabbit Cross Reactivity: (+) iNOS from most mammalian species and nNOS (~5%) (&minus) eNOS Application(s): ICC, IP, and WB NOS catalyzes the biosynthesis of nitric oxide from